The major difference between the present study and others is that our results demonstrated that more CRC patients with early recurrence carried APC mutations than those with late recurrence, though other studies have shown that early recurrence was associated with more KRAS mutations than late recurrence. This evidence concerns the gene KRAS and colorectal carcinoma.